Preferences Of The General Public For Reimbursement Criteria For Expensive Drugs- A Multi Criteria Decision Analysis For Rituximab And Bevacizumab
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1722
https://www.valueinhealthjournal.com/article/S1098-3015(17)32056-9/fulltext
Title :
Preferences Of The General Public For Reimbursement Criteria For Expensive Drugs- A Multi Criteria Decision Analysis For Rituximab And Bevacizumab
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32056-9&doi=10.1016/j.jval.2017.08.1722
First page :
A684
Section Title :
Health Care Use & Policy Studies
Open access? :
No
Section Order :
1555